Sophia Genetics SA Asset Resilience Ratio
Sophia Genetics SA asset resilience ratio. Sophia Genetics SA (SOPH) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SOPH cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sophia Genetics SA (2018–2023)
Asset resilience ratio of Sophia Genetics SA from 2018 to 2023. This chart shows how Sophia Genetics SA's Asset Resilience Ratio has changed over time. Read debt load of Sophia Genetics SA for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sophia Genetics SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SOPH current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Sophia Genetics SA maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Sophia Genetics SA Industry Peers by Asset Resilience Ratio
Compare Sophia Genetics SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Longmaster Information Tech
SHE:300288 |
Health Information Services | 0.68% |
|
Painchek Ltd
AU:PCK |
Health Information Services | 55.69% |
|
Medadvisor Ltd
AU:MDR |
Health Information Services | 12.37% |
|
Trivarx Ltd
AU:TRI |
Health Information Services | 2.55% |
|
Intelicare Holdings Ltd
AU:ICR |
Health Information Services | 64.05% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 17.07% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 32.70% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
Sophia Genetics SA Asset Resilience Ratio by Year (2018–2023)
Sophia Genetics SA asset resilience ratio by year from 2018 to 2023. The table below shows the annual Asset Resilience Ratio data for Sophia Genetics SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $0.00 | $206.16 Million | -- |
| 2022-12-31 | 7.10% | $17.31 Million | $243.84 Million | -15.50pp |
| 2021-12-31 | 22.60% | $72.36 Million | $320.17 Million | +5.40pp |
| 2020-12-31 | 17.20% | $22.72 Million | $132.12 Million | +16.49pp |
| 2019-12-31 | 0.71% | $366.00K | $51.66 Million | +0.17pp |
| 2018-12-31 | 0.54% | $413.00K | $76.62 Million | -- |
About Sophia Genetics SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutic… Read more